We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





AACC Advises Against Using Coronavirus Test CT Values to Guide COVID-19 Patient Care

By LabMedica International staff writers
Posted on 09 Jul 2021
The American Association for Clinical Chemistry (AACC; Washington, DC, USA) has issued a public statement advising against the use of coronavirus test cycle threshold (Ct) values to guide COVID-19 treatment or public health efforts.

The medical community has become increasingly interested in the possibility of using coronavirus test Ct values to improve care for COVID-19 patients and overall management of the pandemic. More...
When a patient gets a standard coronavirus test - known as a qualitative PCR test -Ct values are generated as part of the testing process. These values typically have an inverse relationship with the amount of virus in a patient specimen, with low Ct values indicating a high amount of virus in a sample, and high Ct values indicating the reverse. Because of this, some research has suggested that Ct values could potentially identify patients who have high viral loads and are at increased risk for serious disease. Other findings have also indicated that Ct values could potentially identify patients who aren’t infectious (i.e. those with low viral loads), which could improve contact tracing and outbreak tracking efforts.

However, conclusive data supporting the use of Ct values are lacking. In spite of these studies, many others in the medical community have cautioned against the use of Ct values, arguing that these values have numerous shortcomings and can’t reliably predict disease severity or transmissibility. In order to bring clarity to this issue, AACC members have released a statement that details the limitations of Ct values and recommends against their use. The statement emphasizes that, even though Ct values correlate with the amount of virus in specific specimens, studies have not actually established a relationship between Ct values and a patient’s overall viral load or infectiousness.

There are also numerous factors aside from the amount of virus in a specimen that can impact the Ct values generated during coronavirus testing. AACC’s statement lists all of these factors, which include variables such as patient age, the test instruments used, and even whether or not a patient blows their nose before sample collection. Even with these limitations, though, AACC’s statement acknowledges that clinicians might still want access to Ct values in certain circumstances. If clinical laboratories decide to report Ct values to clinicians who request them, the association recommends that labs include a prominent comment with every report explaining that the use of Ct values to guide patient management is discouraged and why.

“Along with the vaccines, coronavirus testing continues to play a critical role in managing the COVID-19 pandemic around the world,” said AACC President Dr. David G. Grenache. “AACC’s experts have therefore put together this document to provide much-needed guidance on this particular area of coronavirus testing, and to ensure that coronavirus PCR tests continue to be used in a way that best serves patient and public health needs.”

Related Links:
AACC


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.